ArticleGenes2025
Molecular Characteristics, Circularization Mechanism, and Potential Functions of circRNA-0172.
Article in Genes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND/
objectivesAvian leukosis virus subgroup J (ALV-J) harms poultry via tumors and immunosuppression; MDM2-derived circRNA-0172's role in ALV-J infection is unknown. This study explores its molecular characteristics, circularization mechanism and functions for ALV-J control.
methodsCEF/DF-1/HD11 cells were cultured; RNA/DNA was extracted. circRNA-0172 was validated via PCR, sequencing and RNase R; subcellular localization and circularization were analyzed with fractionation and vectors. miRanda/TargetScan/GO/KEGG, CCK-8 and qRT-PCR assessed targets, pathways and functions.
resultscircRNA-0172 (1180 bp, MDM2 exons 3-11) is cytoplasm localized, RNase R resistant, and circularized via flanking ERVL-MaLR repeats. Highly expressed in immune tissues/HD11 cells, it is downregulated by ALV-J. Its overexpression inhibits DF-1 proliferation, downregulates Bcl2 and upregulates CCND1.
conclusionsThis is the first confirmation of circRNA-0172's stability and repeat-dependent circularization; it regulates cell proliferation/apoptosis, providing potential targets for ALV-J-associated avian leukemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.